Giannis Mountzios/X
Dec 20, 2024, 10:11
Giannis Mountzios: End of story for anti-PD1/TIGIT?
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at HENRY DUNANT Hospital Center, shared a post on X:
“End of story for anti-PD1/TIGIT?
Merck announces whole MK-7684A (pembro+vibo) development stopped following both Keyvibe -003/007 in 1L NSCLC meeting futility ctiteria and previous negative press-release in ES-SCLC (Keyvibe-008).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 20, 2024, 10:11
Dec 20, 2024, 10:01
Dec 20, 2024, 09:01
Dec 20, 2024, 06:58
Dec 20, 2024, 06:17
Dec 20, 2024, 02:17
Dec 20, 2024, 02:15